All Experts in Pharmaceutical Sciences

Editors

Dr. Michelle R. Arkin
University of California, San Francisco, USA
Dr. M. Madan Babu
MRC Laboratory of Molecular Biology, UK
Prof. Allan Basbaum
University of California, San Francisco, USA
Dr. Vance Berger
Bethesda, MD, USA
Prof. Claude Bouchard
George A. Bray Jr. Chair in Nutrition and Executive Director, Pennington Biomedical Research Center, Louisiana State University System, USA
Dr. Laura Brown
LB Consulting UK and Cardiff University, UK
Prof. Allen Burton
The University of Texas MD Anderson Cancer Center, USA
Dr. Jeanine Bussiere
Amgen Inc, USA
Dr. Charles Cantor
Sequenom Inc., USA
Prof. Ruth Chadwick
University of Manchester, UK
Prof. Sir Philip Cohen
University of Dundee, UK
Prof. Ann Daly
Newcastle University, UK
Prof. Dr. Erik De Clercq
Katholieke Universiteit Leuven, Belgium
Prof. Ariel Deutch
Vanderbilt University, USA
Dr. Soldano Ferrone
Harvard Medical School, USA
Prof. Robert Gallo
Institute of Human Virology, University of Maryland Baltimore, USA
Prof. Stephen Gillespie
University of St. Andrews, UK
Dr. Paolo Grumati
Institute of Biochemistry II, Goethe University - Faculty of Medicine, Germany
Prof. Vladimir Hachinski
University of Western Ontario, Canada
Dr. Franz Hefti
Chief Scientific Officer Avid Radiopharmaceuticals, Inc.
Prof. Carl-Henrik Heldin
Ludwig Institute of Cancer Research, Sweden
Prof. John Hodges
MRC Cognition and Brain Sciences Unit, University of Cambridge, UK
Dr. Federico Innocenti
Assistant Professor of Medicine, University of Chicago, USA
Prof. Abba Kastin
Pennington Biomedical Research Center, USA
Dr. Wayne Koff
Senior Vice President and Chief Scientific Officer, International AIDS Vaccine Initiative, USA
Prof. Irwin Levitan
Department of Neuroscience and Farber Institute for Neurosciences, Thomas Jefferson University, Philadelphia USA
Dr. Geoffrey Liu
University of Toronto, Canada
Mr. Giles D. Moss
Founder, Pharma Brand Logic, Belgium
Dr. Paul Nunn
Stop TB Department, World Health Organization, Switzerland
Prof. Weihong Pan
BioPotentials Sleep Center, USA
Dr. Mario Raviglione
Stop TB Department, World Health Organization, Geneva, Switzerland
Prof. John Rossi
Chairman and Professor, Division of Molecular Biology, Beckman Research Institute of the City of Hope, USA
Prof. Steven Schachter
Harvard University Medical School, USA
Prof. Jonathan Shaw
Baker IDI Heart and Diabetes Institute, Australia
Prof. Yu Shyr
Vanderbilt University Medical Center, USA
Prof. J. David Spence
Western University, Canada
Prof. Dr. Christoph Steinbeck
Friedrich-Schiller-University, Germany
Prof. Vladimir P. Torchilin
Northeastern University, USA
Dr. Dian Turnheim
Organisation for Economic Co-operation and Development (OECD), France
Dr. Anna Vainshtein
Craft Science Inc., Canada
Prof. Herman Waldmann
Sir William Dunn School of Pathology, University of Oxford, UK
Prof. Thomas J. Webster
Northeastern University, USA
Prof. Paul Zimmet
Baker IDI Heart and Diabetes Institute, Australia

Speakers

Prof. Ian Adcock
Imperial College London, UK
Dr. Robert A. Adler
Hunter Holmes McGuire VA Medical Center, USA
Prof. Ruedi Aebersold
ETH Zurich and University of Zurich, Switzerland
Dr. Cindy Afshari
Amgen Inc., USA
Prof. Michael Akritas
The Pennsylvania State University, USA
Prof. Kari Alitalo
Molecular/Cancer Biology Laboratory, University of Helsinki, Finland
Dr. Krishna Allamneni
Department of Safety Assessment, Genentech, USA
Dr. Mansoor Amiji
Northeastern University, USA
Prof. Sebastian Amyes
University of Edinburgh, UK
Prof. Luis Antunes
University of Trás-os-Montes and Alto Douro, Portugal
Prof. Antonio Anzueto
University of Texas Health Science Center, USA
Dr. Maria Arranz
Institute of Psychiatry, King's College London, UK
Dr. Jonathan D.M. Atkinson
HGF Limited, UK
Prof. Antonio Baici
University of Zurich, Switzerland
Prof. Dr. Jürgen Bajorath
Rheinische Friedrich-Wilhelms-University Bonn, Germany
Prof. Peter Barnes
Imperial College London, UK
Dr. Vincenzo Basile
Centre for Addiction and Mental Health, University of Toronto, Canada
Dr. Norman W. Baylor
Biologics Consulting Group, Inc., USA
Dr. Christine Beedham
Department of Clinical Sciences, University of Bradford, UK
Mr. Hedwig Beernaert
EuroQAM, Belgium
Prof. Stephen Benkovic
The Pennsylvania State University, USA
Dr. Ashley Birkett
PATH Malaria Vaccine Initiative, USA
Dr. Kurt Black
Amgen Inc., USA
Mr. Lee Blansett
Senior Vice President, MattsonJack DaVinci, USA
Prof. Sir Stephen Bloom
Imperial College London, UK
Prof. Jeffrey Blume
Brown University, USA
Prof. Martin Boeree
Radboud University Nijmegen Medical Centre TB Referral Hospital Dekkerswald, Netherlands
Dr. Brad Bolon
GEMpath Inc., USA
Dr. George Borm
Radboud University Medical Centre Nijmegen, Netherlands
Prof. Robert Branch
Center for Clinical Pharmacology, University of Pittsburgh, USA
Prof. Kim Brøsen
Institute of Public Health, Clinical Pharmacology, University of Southern Denmark, Denmark
Dr. Laura Brown
LB Consulting UK and Cardiff University, UK
Dr. Nathan Brown
Institute of Cancer Research, UK
Dr. Roderick Todd Bunch
Drug Safety Evaluation, Bristol Myers Squibb, USA
Dr. Leigh Ann Burns Naas
Gilead Sciences, Inc., USA
Dr. Mark Butt
Tox Path Specialists, USA
Dr. Marc Buyse
Cluepoints Inc., USA, International Drug Development Institute & University of Hasselt, Belgium
Ms. Louise Calder
National Association of Testing Authorities (NATA), Australia
Prof. Sergio Caroli
Instituto superiore di Sanità, Italy
Dr. Joy Cavagnaro
Access BIO, USA
Prof. Bart Celli
Tufts University School of Medicine, USA
Prof. Angela Cenci
University of Lund, Sweden
Dr. Bambos Charalambous
University College London, UK
Ms. Linda Chatwin
UL Health Science Division, USA
Dr. Xun Chen
Sanofi-Aventis, USA
Prof. Fan Chung
Imperial College London, UK
Dr. Tomas Cihlar
Department of Biology, Gilead Sciences, USA
Dr. Daniela Cirillo
San Raffaele Hospital, Milan, Italy
Dr. Jeffrey Clark
Harvard Medical School, USA
Prof. Anthony Coates
St. Georges’ Hospital, University of London, UK
Prof. Frank Cobelens
Academic Medical Center, Amsterdam, Netherlands
Mr. Walter Colasante
Director, FreeLance Health Services Ltd., UK
Prof. Mark Conaway
University of Virginia, USA
Prof. Robert Copeland
Epizyme, USA
Prof. Chris Corrigan
King's College London, UK
Prof. Felicia Cosman
Columbia University, USA
Dr. Geoffrey Coxon
University of Strathclyde, UK
Prof. Charles Craik
University of California, San Francisco, USA
Dr. Charles Crespi
BD Biosciences Discovery Labware, USA
Prof. Jack Cuzick
Wolfson Institute of Preventive Medicine, St. Bartholomew's Medical School, UK
Prof. Ann Daly
Newcastle University, UK
Prof. Paul L. DeAngelis
University of Oklahoma, USA, Caisson Biotech LLC, USA and Hyalose LLC, USA
Dr. Paul Debenham
Life Science, LGC Ltd., UK
Dr. Zeger Debyser
Laboratory for Molecular Virology and Gene Therapy, K.U.Leuven, Belgium
Prof. Dr. Erik De Clercq
Katholieke Universiteit Leuven, Belgium
Prof. Michael W. Deininger
University of Utah, USA
Dr. Elizabeth de Lange
Leiden University, Netherlands
Dr. Christian Delles
Institute of Cardiovascular & Medical Sciences, University of Glasgow, UK
Prof. Edward A. Dennis
University of California San Diego, USA
Dr. Maurice Dickins
Pfizer, UK
Prof. Marc Y. Donath
University Hospital of Basel, Switzerland
Prof. Zoe Draelos
Duke University, USA
Prof. Larry Driver
The University of Texas MD Anderson Cancer Center, USA
Prof. Brian Druker
Oregon Health & Science University Cancer Institute, USA
Prof. Karen Duff
Columbia University Medical Center/NYS Psychiatric Institute, USA
Dr. Erin Duffy
Rib-X Pharmaceuticals Inc, New Haven, USA
Prof. Joe Duffy
St Vincent's University Hospital and University College Dublin, Ireland
Prof. Valerie Durkalski-Mauldin
Medical University of South Carolina, USA
Dr. Christopher Dye
World Health Organization, Switzerland
Prof. Peter R. Ebeling
Monash University, Australia
Prof. Martin Edelman
University of Maryland Greenebaum Cancer Center, USA
Dr. Ian Eltringham
King’s College Hospital, London, UK
Prof. Mark Enright
Imperial College London, UK
Dr. Daniel A. Erlanson
Carmot Therapeutics, Inc., USA
Prof. José Esté
Universitat Autònoma de Barcelona, Spain
Dr. Thomas Evans
Aeras, USA
Dr. Tracey Evans
University of Pennsylvania, USA
Dr. William Evans
St. Jude Children’s Research Hospital, USA
Dr. Nancy Everds
Clinical Pathology, Amgen Inc., USA
Prof. Charles Falany
Department of Pharmacology, University of Alabama at Birmingham, USA
Dr. Patricia Fast
Stanford University School of Medicine, USA
Prof. William Fenical
University of California San Diego, USA
Dr. Mauro Ferrari
Houston Methodist Hospital, USA
Dr. Hugh J. Field
University of Cambridge, UK
Dr. Christopher Fitzpatrick
Stop TB Department at the World Health Organization, Switzerland
Prof. Robert Flisiak
Medical University of Bialystok, Poland
Dr. David Flockhart
Indiana University School of Medicine, USA
Dr. Kendall S. Frazier
GlaxoSmithKline, USA
Prof. Theodore Friedmann
University of California San Diego, USA
Dr. Simone Fulda
University Children's Hospital Ulm, Germany
Res. Prof. Clement Furlong
Div. of Medical Genetics and Genome Sciences, Univ. of Washington, USA
Dr. Sébastian Gagneux
National Institute for Medical Research, UK
Prof. Elizabeth Garrett-Mayer
Medical University of South Carolina, USA
Dr. Marcus Gastreich
BioSolveIT GmbH, Germany
Prof. Stephen George
Duke University School of Medicine, USA
Dr. Don Gerson
PnuVax, Inc, Canada
Prof. Stephen Gillespie
University of St. Andrews, UK
Dr. Marc P. Girard
University of Paris, France
Prof. Aaron D. Gitler
Stanford University School of Medicine, USA
Dr. Philippe Glaziou
Stop TB Department at the World Health Organization, Switzerland
Dr. Larry Gold
SomaLogic, USA
Prof. Edgar Goluch
Northeastern University, USA
Mr. Barry Gowers
Partner, Gowers Consultancy, UK
Dr. William Grant
James Madison University, USA
Dr. David Greaves
University of Oxford, UK
Dr. Joachim M. Greuel
Bioscience Valuation BSV GmbH, Germany
Prof. F. Peter Guengerich
Dept. of Biochemistry, Center in Molecular Toxicology, Vanderbilt University, USA
Dr. Farshad Guirakhoo
Vaxess Technologies, USA
Prof. Mihaly Hajos
Yale University, USA
Dr. Abdel-Bassett Halim
Daiichi-Sankyo, Inc.
Prof. Scott Halstead
International Vaccine Institute, Korea
Prof. Anthony D. Harries
International Union Against Tuberculosis and Lung Disease, UK
Dr. Tim Harris
Biogen Idec., USA
Prof. Robert A. Hauser
University of South Florida, USA
Prof. Frederick G. Hayden
University of Virginia School of Medicine, USA
Mr. Theo Helder
Formerly of the Inspectorate for Health Protection, Netherlands
Mrs. Orienka Hellferscee
National Institute for Communicable Disease, South Africa
Dr. Danuta Herzyk
Merck Research Laboratories, Merck & Co., USA
Prof. Evelyn Hess
Division of Immunology, Department of Internal Medicine, University of Cincinnati Medical Center
Dr. Spencer Phillips Hey
Harvard Medical School, USA
Prof. Anthony J. Hickey
RTI International, USA
Dr. Aroon Hingorani
University College London, UK
Prof. Fred Hirsch
University of Colorado Cancer Center, USA
Dr. Alan Hoberman
Charles River Preclinical Services, USA
Prof. Rikard Holmdahl
Karolinska Institute, Sweden
Dr. Michael V. Holmes
University of Pennsylvania, USA
Dr. Homa Homayoni
University of Texas, USA
Dr. Christiane Honisch
University of California San Diego, USA
Dr. Lee Hood
Institute for Systems Biology, USA
Dr. Ye Hu
Rheinische Friedrich-Wilhelms-University Bonn, Germany
Prof. Steve Humphries
Cardiovascular Genetics, BHF Laboratories, UK
Prof. Magnus Ingelman-Sundberg
Karolinska Institutet, Sweden
Prof. Anastasia Ivanova
The University of North Carolina at Chapel Hill, USA
Dr. Adrian J. Ivinson
Harvard Neurodiscovery Center, USA
Prof. Michael James
University of Alberta, Canada
Dr. Pasi Janne
Dana Faber Cancer Institute and Harvard Medical School, USA
Dr. Kathrin Jansen
Pfizer Vaccine Research & Development, USA
Ms. Gail Javitt
Johns Hopkins University, USA
Dr. Ping Ji
U.S. Food and Drug Administration, USA
Prof. Eric Johnson
Dept. of Molecular and Experimental Medicine, The Scripps Research Institute, USA
Prof. V. Craig Jordan
The University of Texas MD Anderson Cancer Centre, Houston, Texas, USA
Prof. Scott Kahan
Johns Hopkins University Bloomberg School of Public Health, USA
Prof. Eija Kalso
University of Finland, Finland
Prof. Atsushi Kamiya
Johns Hopkins University School of Medicine, USA
Dr. John Kapeghian
Preclinical Safety Associates, USA
Prof. Andrew Kaplan
University of North Carolina, USA
Dr. Jeff Karp
Brigham and Women’s Hospital, USA
Prof. Ruth Karron
Johns Hopkins Bloomberg School of Public Health, USA
Prof. Francine Kaufman
Medtronic, Inc., USA
Prof. Dr. Stefan H. E. Kaufmann
Max-Planck-Institute for Infection Biology, Germany
Prof. Earl R. Kern
University of Alabama, USA
Prof. David Kerr
University of Oxford, UK
Prof. Dongwoo Khang
Gachon University, Korea
Prof. William L. Klein
Northwestern University, USA
Dr. Henrik Klitgaard
UCB, Belgium
Prof. Keith Klugman
Emory University, USA
Dr. Kathleen Knights
Flinders University, Australia
Dr. E. Mick Kolassa
CEO and Managing Partner, Medical Marketing Economics, USA
Prof. Jill Kolesar
University of Kentucky, USA
Dr. Gerald Kovacs
Advanced BioScience Laboratories, USA
Prof. Tatsuki Koyama
Vanderbilt University, USA
Dr. Atina Krajewska
Cardiff University, UK
Dr. Daniela Krause
Massachusetts General Hospital, USA
Dr. Jan Albert Kuivenhoven
Academic Medical Center, Amsterdam, Netherlands
Dr. Arun Kumar
University of Delaware, USA
Dr. Olga Kuznetsova
Merck & Co., Inc, USA
Prof. Sir David Lane
University of Dundee, UK and Institute of Molecular and Cell Biology, Singapore
Prof. Lawrence Lash
Wayne State University School of Medicine, USA
Dr. Dave Leather
GSK Global Respiratory Franchise, UK
Ms. Christinah Leballo
South African National Accreditation System, South Africa
Prof. Brian Leonard
National University of Ireland, Ireland
Prof. Åke Lernmark
Lund University, Sweden
Dr. Michael Lewiecki
University of New Mexico, USA
Dr. Elise Lewis
Charles River Preclinical Services, USA
Prof. James H. Lewis
Georgetown University Medical Center, USA
Prof. Kim Lewis
Northeastern University, USA
Dr. Helen Liddy
Formerly of National Association of Testing Authorities (NATA), Australia
Dr. Christopher Lipinski
Melior Discovery Inc., USA
Prof. Hao Liu
Indiana University School of Medicine, USA
Prof. Huinan Liu
University of California at Riverside, USA
Dr. Jiang Liu
US Food and Drug Administration
Prof. David Livermore
Public Health England’s Antibiotic Resistance Monitoring and Reference Laboratory, UK
Mr. David Long
Long and Associates International Consultancy Ltd., France
Dr. Mark Lowdell
UCL Medical School, UK
Dr. Zhenkun Ma
Global Alliance for TB Drug Development, USA
Dr. Judy A. MacArthur Clark
Animals in Science Regulation Unit (ASRU), Home Office, UK
Ms. Barbara Macelloni
Medical Education Director, Sudler & Hennessey International, Italy
Prof. Peter Mackenzie
Flinders University, Australia
Prof. Carol MacKintosh
University of Dundee, UK
Dr. John Magnani
GlycoMimetics, USA
Prof. Sir Ravinder Maini
Imperial College London, UK
Dr. Lee Makowski
Argonne National Laboratory, USA
Prof. Ben J. Marais
Marie Bashir Institute for Infectious Diseases and Biosecurity (MBI) Centre for Research Excellence in Tuberculosis (TB-CRE) Clinical School, The Children’s Hospital at Westmead The University of Sydney
Prof. Richard Marais
The Institute of Cancer Research, UK
Prof. Maurie Markman
Cancer Treatment Centers of America, USA
Prof. Martin Markowitz
Aaron Diamond Aids Research Center, Rockefeller University, USA
Prof. Sharon Marsh
University of Alberta, Canada
Prof. Giovanni Marsicano
NeuroCentre Magendie, Bordeaux, France
Dr. Mario Masellis
Centre for Addiction and Mental Health, University of Toronto, Canada
Dr. J. Rosser Matthews
Georgetown University, USA
Dr. Patrick Maurel
INSERM, France
Dr. Bernd Mayer
emergentec biodevelopment GmbH, Vienna, Austria
Dr. Michael McClung
Oregon Osteoporosis Center, USA
Prof. Christopher J. McDougle
Indiana University School of Medicine, USA
Mr. Damian McEntegart
ClinPhone Group PLC, UK
Dr. Tim McHugh
University College London, UK
Prof. James Mckerrow
University of California San Francisco, USA
Mr. John McNamee
Instem Life Science Systems Ltd., UK
Prof. Helen McShane
University of Oxford, UK
Dr. Cyrus Mehta
Cytel Inc., USA
Prof. Cornelis Melief
Leiden University Medical Center, Netherlands
Prof. Martin Merkel
University Hospital Hamburg-Eppendorf, Germany
Dr. Jochen Metzger
Mosaiques Diagnostics GmbH, Germany
Prof. John Miners
Flinders University, Australia
Prof. Harald Mischak
University of Glasgow, UK
Prof. Edgar Mocanu
Rotunda Hospital, Ireland
Prof. Peter Moore
Yale University, USA
Prof. Edward T. Morgan
Department of Pharmacology, Emory University of Medicine, USA
Prof. Ralf Morgenstern
Institute of Environmental Medicine, Karolinska Institutet, Sweden
Mr. Giles D. Moss
Founder, Pharma Brand Logic, Belgium
Prof. Lemuel Moye
University of Texas School of Public Health, USA
Prof. David Murdoch
University of Otago, New Zealand
Dr. Sam Nalle
23andMe, USA
Dr. Hisashi Narimatsu
AIST, Japan
Prof. Victor Navarro
Thomas Jefferson University Hospital, USA
Dr. Cameron Neylon
Science and Technology Facilities Council, UK
Prof. Johan Neyts
Rega Institute for Medical Research, K.U.Leuven, Belgium
Mr. Steve Nicholas
Pharmacademy Limited, UK
Prof. Daniel Normolle
University of Pittsburgh, USA
Dr. Andrew Nunn
MRC Clinical Trials Unit, UK
Dr. Paul Nunn
Stop TB Department, World Health Organization, Switzerland
Dr. Tom O'Brien
Genentech, USA
Mr. Nathaniel O’Connell
Medical University of South Carolina, USA
Dr. Isoken Odia
Jaeb Center for Health Research, USA
Dr. Derek O’Hagan
GSK Vaccine Research, USA
Mrs. Susan Ollier
QED Clinical Services, UK
Dr. Anna Olsson
University of Porto, Portugal
Prof. Patrick Onghena
KU Leuven - University of Leuven, Belgium
Prof. Peter Openshaw
Imperial College London, UK
Prof. Albert D.M.E. Osterhaus
Erasmus Medical Centre, Netherlands
Dr. John P. Overington
European Biometrics Institute, UK
Mr. Mike Owen
CEO, Brand Health International, UK
Prof. John Oxford
St. Bartholomew’s, Royal London Hospital, Queen Mary’s School of Medicine and Dentistry, Retroscreen Virology Ltd., UK
Dr. Madhukar Pai
McGill University, Canada
Prof. Gabriel Panayi
King's College London, UK
Prof. Klaus Pantel
University Medical Center Hamburg-Eppendorf, Germany
Dr. Andrea Pantoja
Stop TB Department at the World Health Organization, Switzerland
Ms. Jane Parker
CEO, InterbrandHealth, USA
Dr. Wendy Parulekar
Queen’s University, Canada
Prof. Charles A. Peloquin
University of Florida, USA
Dr. Mark Perkins
FIND, Geneva, Switzerland
Prof. John Petrie
University of Glasgow, UK
Prof. Gina Petroni
University of Virginia, USA
Dr. Marc Pfister
Quantitative Solutions, USA
Prof. Deenan Pillay
University College London, UK
Dr. Mikhail Pletnikov
Johns Hopkins University School of Medicine, USA
Dr. Lisa Plitnick
Merck & Co Inc., USA
Prof. Stanley Plotkin
University of Pennsylvania and Sanofi Pasteur, USA
Dr. Roger Porter
Epilepsy Therapy Project, USA
Prof. Barbara Prainsack
King’s College London, UK
Prof. Mark N. Prichard
University of Alabama, USA
Prof. Margarita Puig
Universitat Autonoma de Barcelona at Hospital del Mar, Spain
Dr. Bronislaw Pytowski
ImClone Systems, USA
Dr. Michael Rafferty
University of Kansas, USA
Dr. Geetha Rajashekhar
Qualtox Consultancy, India
Prof. Rino Rappuoli
Novartis Vaccines and Diagnostics, Italy
Mrs. Katariina Rautalahti
National Supervisory Authority for Welfare and Health, Finland
Prof. Jarkko Rautio
University of Eastern Finland, Finland
Dr. Mario Raviglione
Stop TB Department, World Health Organization, Geneva, Switzerland
Prof. Robert Redfield
Institute of Human Virology, University of Maryland Baltimore, USA
Prof. Allan Rettie
University of Washington, Seattle, USA
Prof. Gavin Reynolds
Queen's University, Belfast, Ireland
Dr. Theresa Reynolds
Department of Safety Assessment, Genentech, USA
Prof. Caroline Robert
Institute Gustave Roussy, France
Prof. Gordon Roberts
Biological NMR Centre, Department of Biochemistry, University of Leicester, UK
Dr. Mark Rogge
Biogen Idec, USA
Prof. William Rosenberger
George Mason University, USA
Prof. John Rossi
Beckman Research Institute of the City of Hope, USA
Prof. Peter Rossing
Steno Diabetes Center, Denmark
Prof. Christian Roux
Paris-Descartes University, France
Mr. Gregory Ruppert
MPI Research, USA
Prof. David Sabatini
Massachusetts Institute of Technology, USA
Dr. Abdul Sankoh
Sanofi-Aventis, USA
Dr. Hélder A. Santos
University of Helsinki, Finland
Dr. R. Dusty Sarazan
Covance Laboratories Inc., USA
Prof. Naveed Sattar
University of Glasgow, UK
Prof. Benjamin Saville
Vanderbilt University and Berry Consultants, USA
Dr. Michael Sawyer
University of Alberta, Canada
Dr. Joost P. Schanstra
INSERM, Toulouse, France
Mr. Maik Schmahl
European Commission, Belgium
Prof. Dieter Schmidt
Epilepsy Research Group Berlin, Germany
Dr. Bruce Schnepp
The Children’s Hospital of Philadelphia, USA
Dr. Birgit Schoeberl
Merrimack Pharmaceuticals, USA
Dr. Erin Schuetz
Department of Pharmaceutical Sciences, St Jude Children's Hospital, USA
Dr. Michael Schwarzschild
Harvard University, USA
Dr. Chloe Sellwood
NHS England, UK
Prof. Ben Seon
Roswell Park Cancer Institute, USA
Prof. Alessandro Serretti
Institute of Psychiatry, University of Bologna, Italy
Prof. Megan Shaw
Mount Sinai, USA
Dr. Todd Sherer
Michael J. Fox Foundation, USA
Prof. Yu Shyr
Vanderbilt University Medical Center, USA
Prof. Richard W. Siegel
Rensselaer Polytechnic Institute, USA
Dr. Peter Siegl
Siegl Pharma Consulting LLC., USA
Mr. Richard Sigman
Organisation for Economic Co-operation and Development (OECD), France
Prof. Edith Sim
Department of Pharmacology, University of Oxford, UK
Dr. Kasha Singh
University College London, UK and Monash University, Australia
Dr. Sirinrath Sirivisoot
King Mongkut’s University of Technology Thonburi, Thailand
Dr. Dennis Smith
Pfizer, UK
Prof. Quentin Smith
Texas Tech University Health Sciences Center, USA
Dr. Hitoshi Someya
Pharmaceuticals and Medical Devices Agency, Japan
Dr. Vernon K. Sondak
H. Lee Moffitt Cancer Center and Research Institute, USA
Dr. Zhou Songyang
Baylor College of Medicine, USA
Prof. J. David Spence
Western University, Canada
Prof. Anton Stalenhoef
Radboud University Nijmegen Medical Centre, Netherlands
Prof. Lawrence Stanberry
Columbia University, USA
Dr. Danica Stanimirovic
National Research Council of Canada, Canada
Prof. Julia Stingl (formerly Kirchheiner)
University of Ulm, Germany
Dr. Joyce Sutcliffe
NanoBio Corporation, USA
Dr. Dan Swerdlow
University College London, UK
Dr. David Swinney
Institute for Rare and Neglected Diseases Drug Discovery, USA
Dr. Patricia Tang
Tom Baker Cancer Centre, Calgary, Canada
Dr. Molly Taylor
AstraZeneca, UK
Prof. Robin Taylor
University of Otago, New Zealand
Prof. Glenn Telling
University of Kentucky, USA
Prof. Jonathan Temte
University of Wisconsin, USA
Prof. Tetsuya Terasaki
Tohoku University, Japan
Dr. Anje te Velde
Academic Medical Center, Netherlands
Dr. Peter Thomas
Covance Laboratories Inc., USA
Prof. Maria Tomasz
Hunter College, City University of New York, USA
Prof. John S. Torday
Harbor-UCLA Medical Center, USA
Prof. David Torgerson
York Trials Unit, University of York, UK
Mr. Gareth Turner
Director of Process Optimisation and Management, PAREXEL Consulting, Inc., UK
Dr. Dian Turnheim
Organisation for Economic Co-operation and Development (OECD), France
Dr. Mukund Uplekar
Stop TB Department at the World Health Organization, Switzerland
Dr. Omar S. Usmani
Imperial College London, UK
Mr. John H. Van Drie
Van Drie Research LLC, USA
Prof. Jonathan Van-Tam
University of Nottingham, UK
Dr. Marietjie Venter
National Institute for Communicable Disease, South Africa
Dr. Sharad K. Verma
GlaxoSmithKline, USA
Prof. Sten H. Vermund
Yale University, USA
Prof. Antonia Vlahou
Bioacademy, Greece
Prof. Paul Volberding
University of California, San Francisco, USA
Prof. Matthias von Herrath
Novo Nordisk Ltd, USA
Prof. Mark Wainberg
McGill University, Canada
Prof. Christine M. Walko
H. Lee Moffitt Cancer Center, Tampa, USA
Dr. Yaning Wang
US Food and Drug Administration
Prof. David Warhurst
London School of Hygiene and Tropical and Medicine, UK
Dr. Amelia Warner
Merck & Co, USA
Prof. Thomas J. Webster
Northeastern University, USA
Prof. Richard Weinshilboum
Mayo Clinic College of Medicine, USA
Dr. Andrea Weir
ToxStrategies, Inc., USA
Dr. Mark Wigglesworth
AstraZeneca, UK
Dr. Dominic Williams
University of Liverpool, UK
Dr. Chris Wilson
Bill and Melinda Gates Foundation, USA
Dr. Daniel Wilson
Ludwig-Maximilians-Universitat Munchen, Germany
Mrs. Pam Wilson
QED Clinical Services, UK
Dr. Peter Wilson
University College London Hospital, UK
Mr. Richard Winning
Winning Process Ltd. UK, UK
Mr. Phil Withers
EUREQA SARL, France
Dr. Neil Woodford
Health Protection Agency, UK
Prof. Ellen Wright Clayton
Vanderbilt University, USA
Prof. Tony Yaksh
University of California, San Diego, USA
Dr. Allen Yang
Amgen Inc. USA
Prof. Lei Yang
Sachoow University, China
Dr. Linda Yau
GlaxoSmithKline, USA
Dr. Tim Yen
Fox Chase Cancer Center, Philadelphia, USA
Prof. Ying Yuan
The University of Texas, USA
Dr. Nathalie Zgheib
American University of Beirut, Lebanon
Prof. Ke Zhang
Northeastern University, USA
Prof. Lijie Grace Zhang
The George Washington University, USA
Dr. Ping Zhang
Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, USA
Dr. Rumin Zhang
Merck, USA
Dr. YanYan Zhou
Florida International University, USA
Dr. Hao Zhu
U.S. Food and Drug Administration, USA
Prof. Paul Zimmet
Baker IDI Heart and Diabetes Institute, Australia
Prof. Fabien Zoulim
Lyon University and INSERM, France